L
LIVE

Serial Number

97427928

Owner

Lantheus Medical Imaging, Inc.

Attorney

Douglas R. Wolf

Filing Date

May 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

L Trademark

Serial Number: 97427928

L is a trademark filed by Lantheus Medical Imaging, Inc. on May 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Lantheus Medical Imaging, Inc.

North Billerica, MA 01862

Entity Type: 03

Trademark Details

Filing Date

May 25, 2022

Registration Date

Not Registered

Published for Opposition

October 3, 2023

Goods & Services

Diagnostic agents, preparations, and substances for medical purposes; imaging agents, preparations, and substances for medical purposes, namely, ultrasound contrast imaging agents for ultrasound diagnostic imaging; preparations for medical purposes, namely, therapeutic preparations for the treatment of cardiovascular diseases and disorders, neurological diseases and disorders, brain conditions, lung diseases and disorders, and cancer

medical services, namely, radiopharmacy nuclear medicine services; providing medical testing services and information in the field of diagnosis, treatment, and prevention of diseases and disorders

Medical apparatus for use in medical imaging, namely, medical devices used for obtaining physical access to contrast media vials and dispensing the contents of contrast media vials; generator of radioactive technetium for clinical use in nuclear medicine; medical apparatus for use in medical imaging, namely, activation apparatus for use in the preparation of ultrasound contrast imaging agents

research and development services in the field of diseases and disorders

promoting public awareness in the field of diseases and disorders

Filing History

SOU TEAS EXTENSION RECEIVED
Apr 10, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 17, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 17, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 16, 2025 EX3G
SOU EXTENSION 3 FILED
May 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Nov 25, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 16, 2024 EX1G
SOU EXTENSION 1 FILED
May 16, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
ASSIGNED TO EXAMINER
Oct 23, 2023 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 12, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 12, 2023 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 20, 2023 GPRN
PRIORITY ACTION E-MAILED
Mar 20, 2023 GPRA
PRIORITY ACTION WRITTEN
Mar 20, 2023 CPRA
ASSIGNED TO EXAMINER
Mar 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2022 NWOS
NEW APPLICATION ENTERED
May 28, 2022 NWAP